| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.0M | -58.9% |
| R&D Expense | $21.8M | +16.1% |
| SG&A Expense | $10.5M | +14.4% |
| Operating Income | -$28.3M | -55.2% |
| Income Tax | $0 | — |
| Net Income | -$27.0M | -65.5% |
| EPS (Basic) | -$2.98 | -47.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.2M | -8.5% |
| Short-term Investments | $12.6M | -57.8% |
| Current Assets | $22.9M | -46.9% |
| Total Assets | $22.9M | -46.9% |
| Current Liabilities | $4.7M | +20.0% |
| Total Liabilities | $4.7M | +20.0% |
| Stockholders' Equity | $18.2M | -53.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.4M | -41.9% |
| Investing Cash Flow | $18.1M | +163.1% |
| Financing Cash Flow | $4.6M | -90.1% |